Cardlytics (CDLX) Tops Q2 EPS by 31c

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.15), $0.31 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $69.64 million versus the consensus estimate of $75.39 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Spacex Now Shares Indicated To Open At $175 Each
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
• US forces in Hormuz help escort oil tankers at night, Burgum says